Showing 15,221 - 15,240 results of 134,598 for search '(( a d decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.13s Refine Results
  1. 15221
  2. 15222
  3. 15223
  4. 15224

    Intrathecal (i.t.) pre- or posttreatment with EphB1-Fc inhibited chronic constrictive injury (CCI)-induced neuropathic pain and spinal Fos protein expression, accompanied by the de... by Li-Na Yu (312492)

    Published 2013
    “…<p>Consecutive intrathecal injection of EphB1-Fc on 1-h before CCI and 1-d and 2-d after CCI in the pre-treatment experiment and Intrathecal injection of a single dose of EphB1-Fc on 5-d after CCI in post-treatment experiment were performed. …”
  5. 15225
  6. 15226

    Supplementary Material for: Fetuses with Isolated Congenital Heart Defects Show Normal Cerebral and Extracerebral Fluid Volume Growth: A 3D Sonographic Study in the Second and Thir... by Jansen F.A.R. (6238655)

    Published 2019
    “…<b><i>Methods:</i></b> A prospective cohort study was conducted in 77 CHD cases, with 75 healthy controls. 3D cerebral volume acquisition was performed sequentially. …”
  7. 15227

    WNT/Frizzled signaling was impaired in <i>DKC1</i> mutant iPS cells. by Bai-Wei Gu (740949)

    Published 2015
    “…The quantitive data, derived by densitometry, are shown. D; Knock down of dyskerin protein can directly decrease the expression of <i>LGR5</i>, <i>WLS</i> and <i>FRZB</i> genes. …”
  8. 15228

    <i>DKC1</i> mutations impair telomerase function in iPS cells. by Bai-Wei Gu (740949)

    Published 2015
    “…Note that <i>A353V</i> iPS cells show decreased level of NHP2 while <i>ΔL37</i> and <i>Q31E</i> cells don’t. …”
  9. 15229
  10. 15230

    The specificity of SATB1 functions in co-regulating the expression of the BCL2 and NOXA genes in the cellular response to apoptosis. by Yin Yang (35103)

    Published 2015
    “…SATB1 levels were determined by Western blot (A). RT–PCR analysis revealed that inhibition of SATB1 degradation reversed the mRNA levels of both BCL2 and NOXA in camptothecin-treated cells (B & C), and significantly suppressed apoptosis (D & E). …”
  11. 15231
  12. 15232
  13. 15233

    4'-O-β-D-glucosyl-5-O-methylvisamminol ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production by suppressing the NF-κB and MAPK sign... by Jing Fu (177892)

    Published 2021
    “…<div><p>Psoriasis is a chronic inflammatory skin disorder in humans, and the inflammatory reaction plays an important role in development and onset of psoriasis. 4'-O-β-D-glucosyl-5-O-methylvisamminol (4GMV) is one of the major active chromones isolated from Saposhnikoviae divaricata (Turcz.) …”
  14. 15234
  15. 15235
  16. 15236

    Serum lipoxin A4 (LXA4) and resolvin D1 (RvD1) deficiency in patients with sleep-disordered breathing. by Yung-Che Chen (381913)

    Published 2019
    “…<p>(A) Serum RvD1 and (B) LXA4 levels were both decreased in patients with primary snoring (PS), treatment-naïve OSA, and severe OSA on CPAP treatment as compared with that in the healthy subjects (HS). …”
  17. 15237

    Real-time measurements of cAMP in response to IBMX in control and AICAR-treated rat AVMs. by Anne Garnier (130125)

    Published 2023
    “…Following CFP excitation at 440±20nm, cAMP binding to the sensor induces a transient decrease in fluorescence resonance energy transfer (FRET) between CFP and YFP plotted as the ratio of the corrected CFP/YFP fluorescence (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0292015#sec002" target="_blank">Materials and Methods</a>). …”
  18. 15238
  19. 15239
  20. 15240